Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan.

BACKGROUND The Japanese government recommended in 2000 that women planning pregnancy should take 400 μg of folic acid daily to decrease the risk of having an infant with spina bifida. We aimed to identify risk factors for the occurrence of spina bifida and to evaluate how the prevalence rate has altered over the past 3 decades. METHODS Subjects comprised 360 women who gave birth to spina bifida-affected offspring and 2333 women who gave birth to offspring without spina bifida between 2001 and 2012. A self-administered questionnaire was used to collect data, which were analyzed by multiple logistic regression models. The prevalence rate of spina bifida was obtained through data provided by international and domestic organizations. RESULTS Four variables were significantly associated with the increased risk of having newborns afflicted with spina bifida: not taking folic acid supplements (odds ratios [OR], 2.50; 95% confidence interval [CI], 1.72-3.64), presence of spina bifida patients within third-degree relatives (OR, 4.26; 95% CI, 1.12-16.19), taking anti-epileptic drugs without folic acid (OR, 20·20; 95% CI, 2.06-198.17), and low birth weight in the newborns ≤ 2500 g (OR, 4.21; 95% CI, 3.18-5.59). The prevalence rate of spina bifida has remained 5 to 6 per 10,000 total births and has not shown any decreasing trend over the past 11 years. CONCLUSION Four risk factors were identified among Japanese women. Because recommendations and information have not decreased the occurrence of spina bifida, the Japanese government should implement mandatory food fortification.

[1]  L. Bailey,et al.  Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I – Folate, Vitamin B12, Vitamin B6 , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  L. Bailey,et al.  Fortification of Flour with Folic Acid , 2010, Food and nutrition bulletin.

[3]  A. Kondo,et al.  Folic acid in the prevention of neural tube defects: Awareness among laywomen and healthcare providers in Japan , 2009, Congenital anomalies.

[4]  K. Meador,et al.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. , 2009, The New England journal of medicine.

[5]  G. Shaw,et al.  Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. , 2008, American journal of epidemiology.

[6]  E. Hertrampf,et al.  National Food-Fortification Program with Folic Acid in Chile , 2008, Food and nutrition bulletin.

[7]  R. Pattinson,et al.  Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. , 2008, Birth defects research. Part A, Clinical and molecular teratology.

[8]  Jane A. Evans,et al.  Reduction in neural-tube defects after folic acid fortification in Canada. , 2007, The New England journal of medicine.

[9]  G. Oakley When will we eliminate folic acid-preventable spina bifida? , 2007, Epidemiology.

[10]  S. Vollset,et al.  International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? , 2005, BMJ : British Medical Journal.

[11]  J. Mills,et al.  Neural tube defect rates before and after food fortification with folic acid. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[12]  K. Michaelsen,et al.  Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? , 2004, Public Health Nutrition.

[13]  D. Young,et al.  The use of folic acid for the prevention of neural tube defects and other congenital anomalies. , 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[14]  Hong Wang,et al.  Correction: Prevention of Neural-Tube Defects with Folic Acid in China. , 1999, The New England journal of medicine.

[15]  M. Khoury,et al.  Neural-tube defects. , 1999, The New England journal of medicine.

[16]  G. Avanzini,et al.  Congenital malformations due to antiepileptic drugs , 1999, Epilepsy Research.

[17]  J. Skurnick,et al.  Study of genetics, epidemiology, and vitamin usage in familial spina bifida in the United States in the 1990s , 1994, Neurology.